一般外科

Medicine & Life Sciences

1. Meta-Analysis 100%
2. Randomized Controlled Trials 64%
3. Systematic Reviews 51%
4. Breast Neoplasms 44%
5. Neoplasms 36%
6. Hepatocellular Carcinoma 34%
7. glucose-regulated proteins 29%
8. Confidence Intervals 28%
9. Neoplasm Metastasis 27%
10. Colorectal Neoplasms 26%
11. Taiwan 25%
12. Rectal Neoplasms 23%
13. Nicotinic Receptors 21%
14. Colonic Neoplasms 20%
15. Cell Movement 19%
16. Therapeutics 19%
17. Nicotine 16%
18. pterostilbene 16%
19. Robotics 15%
20. Odds Ratio 13%
21. Liver 13%
22. PubMed 13%
23. Incidence 12%
24. Apoptosis 12%
25. Laparoscopy 12%
26. Down-Regulation 12%
27. Neoplastic Stem Cells 12%
28. Curcumin 12%
29. Survival 12%
30. Triple Negative Breast Neoplasms 11%
31. MicroRNAs 11%
32. Breast 11%
33. Libraries 11%
34. Carcinogenesis 11%
35. Gastrectomy 11%
36. Bariatric Surgery 10%
37. Epithelial-Mesenchymal Transition 10%
38. Stomach Neoplasms 10%
39. Pain 10%
40. Databases 10%
41. Safety 10%
42. Gastric Bypass 10%
43. Population 9%
44. Lung Neoplasms 9%
45. Autophagy 9%
46. Recurrence 9%
47. Stomach 9%
48. Antrodia 9%
49. Weight Loss 9%
50. Quality of Life 8%
51. Drug Therapy 8%
52. Thrombomodulin 8%
53. Length of Stay 8%
54. Cohort Studies 8%
55. Morbid Obesity 8%
56. Appendectomy 8%
57. Shared Decision Making 8%
58. Colon 8%
59. Serum 7%
60. Advanced Glycation End Products 7%
61. Macrophages 7%
62. Smoking 7%
63. Learning Curve 7%
64. Carcinoma 7%
65. Growth 7%
66. Up-Regulation 7%
67. Fluorouracil 7%
68. Lung 7%
69. Herniorrhaphy 7%
70. Mortality 7%
71. Thyroid Neoplasms 7%
72. Prostatic Neoplasms 7%
73. gemcitabine 7%
74. Proteins 7%
75. Transanal Endoscopic Surgery 6%
76. Survivin 6%
77. Small Interfering RNA 6%
78. Intussusception 6%
79. Catenins 6%
80. Sorafenib 6%
81. In Vitro Techniques 6%
82. Gene Expression 6%
83. SERPIN-B5 6%
84. antrocin 6%
85. Hemorrhage 6%
86. Genes 6%
87. Resveratrol 6%
88. Hormones 6%
89. Retrospective Studies 6%
90. Body Mass Index 6%
91. Phloretin 6%
92. p38 Mitogen-Activated Protein Kinases 6%
93. Wounds and Injuries 5%
94. ErbB Receptors 5%
95. Paclitaxel 5%
96. Postoperative Pain 5%
97. Hydrogen Peroxide 5%
98. Cell Line 5%
99. Survival Rate 5%
100. Inguinal Hernia 5%